BD Biosciences contributions in CD4 counting and immune status for HIV/AIDS.
BD Biosciences is a leader in the use of flow cytometry for determining immune system status and for counting CD4 cells in patients with human immunodeficiency virus (HIV) infection. The company has gained this position through many years of basic research and product development in immunology and cell biology, dye chemistry, immunoassays, instrumentation, and software. Some of the highlights of these developments and their historical perspective are described in this review.
Hoffman
Robert A
RA
BD Biosciences, 2350 Qume Drive, San Jose, CA 95131, USA. bhoffman@bdis.com
Maino
Vernon C
VC
Recktenwald
Diether J
DJ
Webster
H Kyle
HK
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood*; D015704:CD4 Antigens / Q000097:blood*; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology*; D005434:Flow Cytometry / Q000379:methods; D006679:HIV Seropositivity / Q000097:blood*; D019981:Health Care Sector; D006801:Humans; D013677:Medical Laboratory Science
D015704:CD4 Antigens